open access

Vol 29, No 1 (2022)
Technology Note
Submitted: 2021-09-15
Accepted: 2021-10-11
Early publication date: 2021-10-18
Get Citation

Nicotinamide adenine dinucleotide fluorescence to assess microvascular disturbances in post-COVID-19 patients

Marzena Romanowska-Kocejko1, Maria Dudziak1, Marcin Hellmann1
DOI: 10.5603/CJ.a2021.0132
·
Pubmed: 34671964
·
Cardiol J 2022;29(1):154-156.
Affiliations
  1. Department of Cardiac Diagnostics, Medical University, Gdansk, Poland

open access

Vol 29, No 1 (2022)
Technology note — COVID-19
Submitted: 2021-09-15
Accepted: 2021-10-11
Early publication date: 2021-10-18

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Nicotinamide adenine dinucleotide fluorescence to assess microvascular disturbances in post-COVID-19 patients

Journal

Cardiology Journal

Issue

Vol 29, No 1 (2022)

Article type

Technology Note

Pages

154-156

Early publication date

2021-10-18

Page views

1189

Article views/downloads

348

DOI

10.5603/CJ.a2021.0132

Pubmed

34671964

Bibliographic record

Cardiol J 2022;29(1):154-156.

Authors

Marzena Romanowska-Kocejko
Maria Dudziak
Marcin Hellmann

References (10)
  1. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395(10234): 1417–1418.
  2. Gasecka A, Pruc M, Kukula K, et al. Post-COVID-19 heart syndrome. Cardiol J. 2021; 28(2): 353–354.
  3. Lowenstein CJ, Solomon SD. Severe COVID-19 is a microvascular disease. Circulation. 2020; 142(17): 1609–1611.
  4. Østergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep. 2021; 9(3): e14726.
  5. Maccio U, Zinkernagel AS, Shambat SM, et al. SARS-CoV-2 leads to a small vessel endotheliitis in the heart. EBioMedicine. 2021; 63: 103182.
  6. Hellmann M, Roustit M, Cracowski JL. Skin microvascular endothelial function as a biomarker in cardiovascular diseases? Pharmacol Reports. 2015; 67(4): 803–810.
  7. Katarzynska J, Lipinski Z, Cholewinski T, et al. Non-invasive evaluation of microcirculation and metabolic regulation using flow mediated skin fluorescence (FMSF): Technical aspects and methodology. Rev Sci Instruments. 2019; 90(10): 104104.
  8. Tarnawska M, Dorniak K, Kaszubowski M, et al. A pilot study with flow mediated skin fluorescence: A novel device to assess microvascular endothelial function in coronary artery disease. Cardiol J. 2018; 25(1): 120–127.
  9. Hellmann M, Tarnawska M, Dudziak M, et al. Reproducibility of flow mediated skin fluorescence to assess microvascular function. Microvasc Res. 2017; 113: 60–64.
  10. Gebicki J, Katarzynska J, Marcinek A. Can efficient stimulation of myogenic microcirculatory oscillations by transient ischemia predict low incidence of COVID-19 infection? Respir Physiol Neurobiol. 2021; 286: 103618.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl